First evidence of resistance to macrocyclic lactones, in<i> Psoroptes ovis</i> sheep scab mites in the UK by Doherty, Emma et al.
                          Doherty, E., Burgess, S., Mitchell, S., & Wall, R. (2018). First evidence of
resistance to macrocyclic lactones, in Psoroptes ovis sheep scab mites in the
UK. Veterinary Record, 182(4), [e104657].
https://doi.org/10.1136/vr.104657
Peer reviewed version
Link to published version (if available):
10.1136/vr.104657
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via BMJ at http://veterinaryrecord.bmj.com/content/early/2018/01/09/vr.104657 . Please refer to any applicable
terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
1 
 
First evidence of resistance to macrocyclic lactones, in 
Psoroptes ovis sheep scab mites in the UK 
Emma Doherty, Stewart Burgess, Sian Mitchell & Richard Wall 
 
E. Doherty BSc 
School of Biological Sciences, University of Bristol, Bristol, BS8 1TQ 
S. Burgess BSc, PhD 
Moredun Research Institute, Pentlands Science Park, Bush Loan, Midlothian, EH26 0PZ 
E.S.E Mitchell BVMS, PhD, MRCVS 
APHA Carmarthen Investigation Centre, Carmarthen, SA31 3EZ 
*R. Wall BSc, MBA, PhD 
School of Biological Sciences, University of Bristol, Bristol, BS8 1TQ 
 
Abstract 
Ovine psoroptic mange (sheep scab) is an infection of substantial economic and animal welfare 
concern in the UK. Its prevalence has increased rapidly over the last 20 years and management is 
dependent on a small number of acaricidal compounds, many of which are also used to control a 
range of other endo- and ectoparasites. Here, the effects of the macrocyclic lactone (ML) moxidectin 
was considered using in vitro assays against mites from four farm populations where persistent 
treatment failure had been reported: two in west Wales, one from the England/Wales border and 
one in Herefordshire. The data demonstrate resistance in mites from all four farms. This is the first 
quantitative evidence of ML resistance in Psoroptes mites in the UK. Given the similarities in their 
mode of action it is highly likely that cross-resistance across the range of this class of compound will 
be found. The development of resistance to moxidectin is of considerable concern given the already 
high prevalence of scab infection in some regions; major difficulties in scab management should be 
anticipated if ML resistance becomes widely established in the UK. 
 
*Correspondence author;  Email: richard.wall@bristol.ac.uk  
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Introduction  
Ovine psoroptic mange (sheep scab) is caused by an acute hypersensitivity reaction to the parasitic 
mite, Psoroptes ovis, leading to dermatitis, intense pruritus, self-trauma, weight loss and, in some 
cases, mortality (Roberts and others 1971). Immediately prior to its deregulation in the UK it was 
compulsory to treat all sheep prophylactically and, by 1988 when twice yearly immersion dipping 
was enforced, there were fewer than 40 reported outbreaks per year (French and others 1999). 
Following deregulation in 1992, many farmers abandoned prophylactic treatment, particularly with 
organophosphate insecticides (French and others 1994; Bisdorff and others 2006). Over the 
subsequent 20 years, the prevalence of scab increased substantially, while showing strong regional 
variation, with an average of 13.9% of flocks reporting at least one outbreak per year in Scotland, 
Northern England and Wales (range 7.1-20.5%) compared to 5.2% of flocks reporting at least one 
outbreak per year in Central, East and South West England (range 3.3-6.4%) (Bisdorff and others 
2006; Rose and Wall 2012). The Sheep Scab (Scotland) Order 2010 once again made the disease 
notifiable in Scotland.  
Regional differences within the UK have been attributed to the greater use of common grazing in 
upland areas since unrestricted mixing of animals facilitates transmission from infected to 
uninfected animals and makes prompt disease management more difficult (Rose and Wall 2012).  
Modelling analyses have demonstrated that in the prevailing economic conditions the use of 
prophylaxis is not a cost-effective scab management strategy for farmers, particularly for lowland 
sheep in areas where infection risk is relatively low (Nixon and others 2017).  However, for farmers 
in upland areas, where infection risk is high, routine prophylaxis is cost-effective and an important 
welfare consideration.   
There are two primary prophylactic treatments for scab prevention currently licensed in the UK: a 
long-acting injectable formulation of the macrocyclic lactone (ML) moxidectin and the 
organophosphate (OP), Diazinon, which must be used as a total-immersion plunge dip (Sargison and 
others 2007). When used as a preventative measure, a single injection of long acting 2% moxidectin 
can provide protection for up to 60 days (NOAH 2014). Diazinon plunge dip, confers protection for 
up to 63 days (Kirkwood and Quick, 1981). A range of other macrocyclic lactone products, such as 
doramectin or ivermectin, with relatively shorter residual activity, or Diazinon organophosphate dip 
can also be used reactively to treat scab.  However, recent anecdotal reports of persistent treatment 
failure after the use of macrocyclic lactones have increased, particularly from Wales and the Welsh 
borders. The aim of this study, therefore, was to investigate whether such reports might indicate the 
initial stages of the development of resistance to macrocyclic lactones in the UK.   
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Methods and Materials 
A laboratory bioassay was developed based on that described by Brimer and others (1995). Test 
plates were produced by filling sterile Petri-dishes (internal diameter 85 mm) with approximately 20 
ml of sterile agar solution (agar base 40 g/l and 5% v/v of normal sheep serum) containing 1 ml of 
the macrocyclic lactone moxidectin (Cydectin 2% LA (Long Acting) Injection for Sheep, Zoetis Animal 
Health) diluted to varying concentrations in 100% ethanol, which were added to the agar solution 
just prior to the casting of the dishes to create concentrations of 500, 1000 or 2000 ng/ml. Negative 
control plates were made up by adding 1 ml of 100 % ethanol only to the agar solution in place of 
the moxidectin.  
Psoroptes mites were derived from two sources.  First, mites were collected from infested sheep 
maintained at the Moredun Research Institute (MRI). These sheep had never been treated for scab 
and the mite population had been in continuous passage, without exposure to acaricide, for at least 
10 years. Second, P. ovis were collected from scab outbreaks; two in west Wales (Ceredigion and 
Camarthenshire), one from the Wales/England border (Hay-on-Wye) and one from England 
(Leominster, Herefordshire).  Sheep on these farms had all been treated previously with various 
injectable acaricides but had failed to respond to treatment showing persistent signs of P. ovis 
infestation. Mites were removed from samples of wool and skin scrapings collected by the flock 
owner or veterinary surgeon.   
Following collection and prior to experimental use, mites were held at 6 °C and were used within 3 
days of collection. A maximum of 10 mites were added per Petri-dish at the centre of the agar; 
adults, tritonymphs or protonymphs were not distinguished; larvae were not used.  Petroleum jelly 
was applied to the rim of the Petri-dish and Parafilm was used to seal it to prevent the mites from 
escaping. After sealing, the Petri-dishes were placed into an incubator at 80 % relative humidity and 
a temperature of 20 ᵒC. Mites were inspected under a dissecting microscope every 24 hours and 
were considered dead if they demonstrated no movement after mechanical stimulation for 15 
seconds with a fine paintbrush.   
Large numbers of mites could be collected from the MRI infested animals, so the full range of 
moxidectin concentrations could be tested.  MRI mites exposed to agar containing ethanol only are 
described as negative controls (MRI-) and MRI mites exposed to agar containing moxidectin are 
described as positive controls (MRI+).  For all tests with MRI mites, there were three replicates for 
each moxidectin concentration used and the entire test was repeated twice at a four month interval, 
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with two independent collections from infested MRI sheep; data were then pooled for analysis. The 
outbreaks from west Wales and Leominster yielded relatively small numbers of mites and so these 
were exposed to only a single concentration of moxidectin of 500 ng/ml. The scab outbreak from 
Hay-on-Wye yielded larger numbers of mites and these were exposed to moxidectin at 1000 ng/ml 
and 2000 ng/ml. 
The percentage mortality in each Petri-dish was ARCSIN transformed to normalise the variance 
before means were compared using one-way ANOVA with Tukey post-hoc tests.   
 
Results 
The mites collected from MRI and exposed to ethanol/agar only (MRI-), showed a gradual increase in 
mortality over 120 hours, reaching approximately 60% mortality by 120 hours after exposure (Fig. 1). 
When mites from MRI were exposed to agar containing 500ng/ml of moxidectin (MRI+), they 
showed a significantly higher rate mortality than the negative controls (MRI-), reaching 
approximately 90% mortality after 120 hours (df= 2; F= 4.9; P<0.05, Fig 1), showing that MRI mites 
were highly susceptible to moxidectin.  In contrast, when exposed to 500 ng/ml of moxidectin the 
mites from the three field outbreaks (west Wales and Leominster) showed low levels of mortality, 
similar to that seen in the MRI mites exposed to ethanol only (MRI-) (df=2; F=6.8; P>0.05, Fig 1). 
When exposed to moxidectin at 2000 ng/ml and 1000 ng/ml, positive control (MRI+) showed very 
high rates of mortality, approaching 100% after 72 h (Fig. 2). In contrast mites from the field 
outbreak from Hay-on-Wye showed low levels of mortality, with only 20-30% mortality after 120 h.  
This was significantly lower than that observed with the MRI mites (MRI+) exposed to similar 
concentrations of moxidectin (df=2; F=32.7; P < 0.05, Fig 2).  
 
Discussion 
When large numbers of sheep are treated with a small number of acaricides or insecticides the 
development of resistance is almost inevitable (Bates 1998).  Resistance in P. ovis to synthetic 
pyrethroids was first confirmed in the UK in 1995 (Synge and others 1995) and in 1996–1997 there 
were at least 20 cases of suspected pyrethroid resistance detected (Coles 1998). The first case of 
resistance to the organophosphate propetamphos was described in 1996 (Clark and others 1996). Of 
particular concern in the UK with regard to resistance development is the fact that the same class of 
ML compounds is heavily relied upon for the control/treatment of a wide range of ecto- and 
5 
 
endoparasites, thus increasing the rate of application and exposure and inadvertently accelerating 
the rate of selection for resistance across a range of parasite taxa (Sargison and others 2007).  
Here, four field populations of mites were collected from flocks which had shown persistent 
treatment failure to ML treatments. Analysis of sheep plasma 0.5 days after treatment with 
subcutaneous injection of moxidectin suggests that a plasma concentration of approximately 10-20 
ng/ml might be expected (Lloberas and others 2013). While this was used as a guide to the dose 
range used here, the concentrations of moxidectin required to achieve mortality rates that were 
significantly different to that of the MRI-derived negative controls, were considerably higher (> 500 
ng/ml). The manner in which the bioassay used affects the mites is therefore unclear; the mites may 
have ingested the top layer of agar or they may have been absorbing the active ingredient through 
the cuticle, but given the relatively high concentration required to achieve mortality, the latter is 
more likely.  
Regardless of its precise mode of action, the data presented strongly suggest that treatment failure 
is likely to have been due to acquired resistance; the assay demonstrated good levels of mortality at 
concentrations of 500 ng/ml and above in MRI mites that had not previously been exposed to 
acaricides, but exposure to this concentration failed to give equivalent levels of mortality in all four 
field populations. This is the first demonstration of moxidectin resistance in Psoroptes mites in the 
UK. Given the similarities in their mode of action as GABA agonists, stimulating the binding of 
neurotransmitter and inducing paralysis in arthropods and nematodes (Nakao and Banba 2015), it is 
highly likely that cross-resistance across the range of this class of compound will be detected. 
Current work is underway to test this conclusion and more precisely identify a discriminating dose.  
The development of resistance to MLs is of considerable concern given the already high prevalence 
of scab infection in some regions. Psoroptic mange is widespread in cattle in Belgium, affecting the 
Belgian Blue breed in particular. Treatment failures following injectable ivermectin suggest that ML 
resistance is widespread in the Belgian population of mites, resulting in great difficulty in its effective 
management (Lekimme and others 2010); a difficulty also encountered when cattle mange was 
introduced into the UK (Mitchell and others, 2012).  This highlights the potential problems that are 
likely to be encountered should ML resistance become more widely established in sheep scab mites 
in the UK, leaving very few options for its effective management.  
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Figure Legends 
 
Fig 1. The percentage mortality of Psoroptes ovis mites over time (hours) exposed in an in vitro 
bioassay to moxidectin in agar at 500 ng/ml (circles) or ethanol in agar only (squares).  Mites 
were derived either from three farm outbreaks (Red lines: Leominster, Ceredigion or 
Carmarthenshire) with known histories of treatment failure or from a culture at the Moredun 
Research Institute (MRI) with no history of acaricide treatment (black lines). The MRI mites 
were exposed to agar/moxidectin to provide positive controls (MRI+) or ethanol/agar only to 
provide negative controls (MRI-). 
 
Fig 2. The percentage mortality of Psoroptes ovis mites over time (hours) exposed in an in vitro 
bioassay to moxidectin in agar at 1000ng/ml (circles) or 2000ng/ml (diamonds) or ethanol only 
controls (squares).  Mites were derived either from one farm outbreak (Hay-on-Wye) with a 
known history of treatment failure (red lines) or from a culture at the Moredun Research 
Institute (MRI) with no history of acaricide treatment (black lines). The MRI mites were 
exposed to agar/moxidectin to provide positive controls (MRI+) or ethanol/agar only to provide 
negative controls (MRI-). 
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